Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2024-05-13 00:00:00 ET · period of report 2024-05-10 · accession 0001214659-24-008874 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-13 | 2024-05-10 | AQST | Wargacki Stephen | CSO | A - Grant | $0.00 | +10.0K | 268.0K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-10 | A | A | 10,000 | $0.00 | 267,963 | D | — | — | (F1) The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |